REVB (Revelation Biosciences) FFO


REVB Revelation Biosciences Inc REVB
28 GF Score
Price $0.98
! 1 Warning Sign
View Full Analysis

What is Revelation Biosciences FFO?

FFO (Funds from operations) only applies to REITs.

REVB
28GF Score
Revelation Biosciences Inc REVB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revelation Biosciences Business Description

Address 4660 La Jolla Village Drive, Suite 100, San Diego, CA, USA, 92122
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
28GF Score

Get the complete analysis for REVB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price